S&P 500

5.321,41

0,25%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Femasys Inc (FEMY)
Femasys Inc (FEMY) Notícias

FEMY

Femasys (FEMY)

Femasys Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:FEMY

1 2 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
17/05/2024	09:30	GlobeNewswire Inc.	Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Office of Science and Technology Policy to Discuss the Cancer Moonshot Initiative	NASDAQ:FEMY	Femasys Inc
16/05/2024	09:30	GlobeNewswire Inc.	Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Gender Policy Council	NASDAQ:FEMY	Femasys Inc
09/05/2024	09:40	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FEMY	Femasys Inc
09/05/2024	09:35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FEMY	Femasys Inc
09/05/2024	09:30	GlobeNewswire Inc.	Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate Update	NASDAQ:FEMY	Femasys Inc
07/05/2024	09:30	GlobeNewswire Inc.	Femasys Expands Commercial Management Team with Addition of Experienced New Hires	NASDAQ:FEMY	Femasys Inc
18/04/2024	09:30	GlobeNewswire Inc.	Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare Initiatives	NASDAQ:FEMY	Femasys Inc
28/03/2024	17:05	GlobeNewswire Inc.	Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update	NASDAQ:FEMY	Femasys Inc
21/03/2024	10:00	GlobeNewswire Inc.	Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape	NASDAQ:FEMY	Femasys Inc
20/03/2024	09:15	GlobeNewswire Inc.	Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility	NASDAQ:FEMY	Femasys Inc
13/03/2024	10:00	GlobeNewswire Inc.	Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024	NASDAQ:FEMY	Femasys Inc
06/03/2024	11:00	GlobeNewswire Inc.	Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution	NASDAQ:FEMY	Femasys Inc
13/02/2024	23:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FEMY	Femasys Inc
13/02/2024	23:44	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:FEMY	Femasys Inc
11/12/2023	02:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:FEMY	Femasys Inc
08/12/2023	11:28	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:FEMY	Femasys Inc
30/11/2023	19:17	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:FEMY	Femasys Inc
22/11/2023	18:12	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:FEMY	Femasys Inc
15/11/2023	10:30	Business Wire	PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.	NASDAQ:FEMY	Femasys Inc
07/08/2023	09:40	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:FEMY	Femasys Inc
28/07/2023	18:15	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:FEMY	Femasys Inc
07/07/2023	17:26	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:FEMY	Femasys Inc
26/06/2023	09:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FEMY	Femasys Inc
16/06/2023	17:37	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:FEMY	Femasys Inc
16/05/2023	17:37	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:FEMY	Femasys Inc
15/05/2023	07:29	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:FEMY	Femasys Inc
15/05/2023	07:29	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:FEMY	Femasys Inc
05/05/2023	17:02	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:FEMY	Femasys Inc
28/04/2023	07:17	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:FEMY	Femasys Inc
20/04/2023	10:40	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:FEMY	Femasys Inc